We have been informed by our wholly owned subsidiaries of that pursuant to conversion of its status from private limited company to public limited company, its name has been changed from: 1. 'IBL Healthcare Private Limited' to 'IBL Healthcare Limited' 2. 'HSL Agri Solutions Private Limited' to 'HSL Agri Solutions Limited'. Please find enclosed herewith the attachment pertaining to the same for your records

Pursuant to the Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith the copy of newspaper publications pertaining to Audited Financial Results for the quarter and year ended 31st March, 2022 published in Trinity Mirror in English Language and Makkal Kural in Tamil Language on 1st June 2022.

The Board of Directors at its meeting held today, viz. May 30, 2022, has considered and approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2022. A copy of duly signed audited financial results along with audit reports and declaration in respect of audit report with unmodified opinion under Regulation 33 of Listing Regulations, is enclosed. The meeting of the Board of Directors commenced at 9.00 p.m. and concluded at 10.00 p.m. Kindly take the aforesaid information on your records.

The Board of Directors at its meeting held today, viz. May 30, 2022, has considered and approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2022. A copy of duly signed audited financial results along with audit reports and declaration in respect of audit report with unmodified opinion under Regulation 33 of Listing Regulations, is enclosed. The meeting of the Board of Directors commenced at 9.00 p.m. and concluded at 10.00 p.m. Kindly take the aforesaid information on your records.

Please find enclosed herewith the Annual Secretarial Compliance Report for the financial year ended on March 31, 2022 as per Regulation 24A of the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019. Request you to kindly take the same on records.

This is further to our intimation dated 14th November 2021, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, relating to incorporation of a wholly owned subsidiary of Indrayani Biotech Limited. Further to the above intimation, a wholly owned subsidiary company in the name and style of 'IBL Investments Limited' has been incorporated on 24th May 2022 with CIN: U65990TN2022PLC152486.

INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve 1. The Audited Financial Results with Audit Report for the year ended 31st March, 2022. 2. Any other business with the permission of the Chair.

This is to inform you that Indrayani Biotech Limited in line with the company's philosophy of aggregation and assimilation of suitable business to achieve vertical and inclusive growth, is in the process of associating with Dindigul Farm Product Private Limited. Please find attached herewith the disclosure with respect to MoU entered between Indrayani Biotech Limited and Dindigul Farm Product Private Limited.

This is to inform you that Indrayani Biotech Limited in line with the company's philosophy of aggregation and assimilation of suitable business to achieve vertical and inclusive growth, is in the process of associating with A R Diary Food Private Limited. Please find attached herewith the disclosure with respect to MoU entered between IBL and AR.

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jayaseelan S